Received Apr 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | 1 | UT8470CA | IM / LA |
On 3/11/2025-1 day after immunization was given patient had swelling at injection site and localized redness and warmth this has persisted since vaccine was given on 3/10/2025. Patient presented to the clinic on 4/3/2025 for further evaluation of the swelling with overlying redness of the skin. On exam patient had an approximate 4 cm x 4 cm x 1.5 to 2 cm deep to skin area of swelling with overlying erythema. Denied fever, chills, shortness of breath or other infectious symptoms. Unable to rule out infection so doxycycline 100 mg twice daily was started and an ultrasound of the area of swelling was ordered along with a CBC and a CRP.
no acute illness
Hypertension, morbid obesity, irritable bowel syndrome, GERD, hyperlipidemia, diabetes mellitus, rheumatoid arthritis, osteoarthritis, degenerative disc disease, polymyalgia rheumatica, fibromyalgia, COPD, obstructive sleep apnea, chronic kidney disease stage IIIa, spinal stenosis, depression
OTC: Zinc, B complex vitamin. Prescription: simvastatin 20 mg daily, entresto 24-26 mg BID, lyrica 300 mg BID, potassium chloride 10 meq BID, omeprazole 40 mg daily, zaroxolyn 2.5 mg daily prn, mobic 7.5 mg daily prn, meclizine 25 mg TID P
none
US left deltoid at area of swelling, CBC, and CRP. No test results available at time of report, all ordered on 4/3/25.